Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 950 of 1361 entries
View as:

Feasibility of Reducing Respiratory Drive Using the Through-flow System

Phase: N/A Priority: Normal
NCT ID: NCT05642832 Org: User:
Start: 01/01/24 End: 08/31/25 Due: 08/31/26

Exercise in Patients With Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03390569 Org: User:
Start: 08/29/17 End: 12/23/21 Due: 12/23/22

Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay

Phase: N/A Priority: Normal
NCT ID: NCT03558165 Org: User:
Start: 03/01/18 End: 02/18/22 Due: 02/18/23

Effects of Exemestane on Bone Strength

Phase: N/A Priority: Normal
NCT ID: NCT01144468 Org: User:
Start: 04/30/07 End: 01/31/22 Due: 01/31/23

Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

Phase: N/A Priority: Normal
NCT ID: NCT00152932 Org: User:
Start: 05/31/05 End: 06/30/06 Due: 06/30/07

The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00188604 Org: User:
Start: 01/31/04 End: 01/31/09 Due: 01/31/10

Brain Insulin Resistance in Mood Disorders

Phase: N/A Priority: Normal
NCT ID: NCT03915613 Org: User:
Start: 10/06/21 End: 10/05/24 Due: 10/05/25

Sexual Health and Rehabilitation eClinic (SHAReClinic)

Phase: N/A Priority: Normal
NCT ID: NCT03396848 Org: User:
Start: 08/23/17 End: 12/31/21 Due: 12/31/22

My Cardiac Recovery (MyCaRe): A Pilot RCT.

Phase: N/A Priority: Normal
NCT ID: NCT02778165 Org: User:
Start: 10/01/22 End: 06/30/24 Due: 06/30/25

Atypical Fracture Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT01747291 Org: User:
Start: 06/30/09 End: 12/31/26 Due: 12/31/27

The Role Of Noninvasive 320-Row Multidetector Computer Tomography

Phase: N/A Priority: Normal
NCT ID: NCT01405690 Org: User:
Start: 09/30/08 End: 02/29/16 Due: 02/28/17

At Home Monitoring for Patients With Covid19

Phase: N/A Priority: Normal
NCT ID: NCT04453774 Org: User:
Start: 11/01/20 End: 06/01/24 Due: 06/01/25

Periperal Blood Lymphocytes During Prostate RT

Phase: N/A Priority: Normal
NCT ID: NCT01899391 Org: User:
Start: 08/31/09 End: 03/31/13 Due: 03/31/14

Ketamine and fMRI for Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT02373449 Org: User:
Start: 02/28/15 End: 12/31/20 Due: 12/31/21

A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02483312 Org: User:
Start: 09/30/15 End: 08/31/25 Due: 08/31/26

Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01334099 Org: User:
Start: 07/31/10 End: - Due: -

Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study)

Phase: N/A Priority: Normal
NCT ID: NCT00297024 Org: User:
Start: 02/28/05 End: 05/31/13 Due: 05/31/14

Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients

Phase: N/A Priority: Normal
NCT ID: NCT04107311 Org: User:
Start: 09/05/19 End: 03/05/25 Due: 03/05/26

HBOT Late Radiation Tissue Injury

Phase: N/A Priority: Normal
NCT ID: NCT02425215 Org: User:
Start: 06/30/14 End: 04/30/20 Due: 04/30/21

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03016338 Org: User:
Start: 11/06/17 End: 12/31/25 Due: 12/31/26

Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations

Phase: N/A Priority: Normal
NCT ID: NCT03839342 Org: User:
Start: 06/07/19 End: 12/31/25 Due: 12/31/26

Pilot Study of Remote Ischemic Preconditioning in Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01128790 Org: User:
Start: 10/31/09 End: 06/30/11 Due: 06/30/12

HBOT Global Functioning After Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02666469 Org: User:
Start: 10/31/15 End: 12/31/18 Due: 12/31/19

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

Phase: N/A Priority: Normal
NCT ID: NCT02370758 Org: User:
Start: 11/30/14 End: 06/16/17 Due: 06/16/18

HBOT in Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT02467218 Org: User:
Start: 11/30/15 End: 12/31/18 Due: 12/31/19